Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD | Zendy

Jia Sun | Zendy; Jonas Axelsson | Zendy; Anna Machowska | Zendy; Olof Heimbürger | Zendy; Peter Bárány | Zendy; Bengt Lindholm | Zendy; Karin Lindström | Zendy; Peter Stenvinkel | Zendy; Abdul Rashid Qureshi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

Author(s) -

Jia Sun,

Jonas Axelsson,

Anna Machowska,

Olof Heimbürger,

Peter Bárány,

Bengt Lindholm,

Karin Lindström,

Peter Stenvinkel,

Abdul Rashid Qureshi

Publication year - 2016

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.10441015

Subject(s) - medicine , ferritin , c reactive protein , diabetes mellitus , hazard ratio , wasting , gastroenterology , white blood cell , dialysis , kidney disease , confidence interval , inflammation , endocrinology

The high risk of cardiovascular disease (CVD) and premature death in patients with CKD associates with a plethora of elevated circulating biomarkers that may reflect distinct signaling pathways or simply, are epiphenomena of CKD. We compared the predictive strength of 12 biomarkers analyzed concomitantly in patients with stage 5 CKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research